News

Recently, Rein Therapeutics (referred to as "Rein", NASDAQ stock code: RNTX), a biopharmaceutical company, announced that it has been aut...

On October 9, 2025, Chengdu Newruit Medical Technology Co., Ltd. (hereinafter referred to as Newruit Medical) recently completed a Series D financi...

On September 29, 2025, Metsera (acquired by Pfizer) announced positive results from two weight loss phase 1b studies (VESPER-1 and VESPER-13) of ME...

On September 29, 2025, Hangzhou Yaoaccelerated Medical Isotope Technology Co., Ltd. (hereinafter referred to as "Yaoaccelerated"), a hard...

We recently successfully obtained an order of retatrutide products from a German client, further expanding our business footprint in the European m...

We recently established in-depth cooperation with a valued UAE customer and successfully secured a tropicamide order, a testament to the trust forg...

We recently reconnected with our long-term Brazilian customer and secured a Tirzepatide order, reaffirming the profound trust built between us over...

We recently secured a repeat order from a U.S. customer, who placed an order for multiple specifications of our core products including Retatrutide...

We recently secured a trial order for Red Phosphorus powder with a German customer, who plans to transport the product to Poland. This cooperation ...

We provide GLP-1 peptide , please refer to the following website for detailed specifications and product information. Product: https://www.bloomtec...

Xinlitai releases Phase I research data on SiRNA therapy for hypertension On March 31, 2026, Xinli Tai announced that it had recently unveiled the ...

According to the national legal holiday regulations and the actual situation of our company, the May Day holiday arrangement is announced as follow...